- to vasoconstriction function p38-MAPK endothelial mitogen-activated phosphorylation endothelium p38 endothelin coronary cardiovascular research medicine vasoactive peptides MAPK dysfunction hypertension cardiology protein kinase by avivagabriel on Aug 8, 2007, 2:19 AM
Mitogen-activated protein kinase p38 is a serin/threonine kinase originally isolated from lipopolysaccharide stimulated monocytes. There are 4 isoforms; p...Mitogen-activated protein kinase p38 is a serin/threonine kinase originally isolated from lipopolysaccharide stimulated monocytes. There are 4 isoforms; p38-a activation has been most widely studied for inflammation...
to disease amgen p38-MAPK mitogen-activated cytokines inflammatory p38 p38-alpha inflammation IL-1-beta cytokine alpha phosphorylation activation kinase protein TNF-alpha by avivagabriel on Aug 7, 2007, 11:25 PMBMC Pharmacol. 2002. H Kenneth Kramer, et al.
to tyorsine phosphorylation opioid protein delta p38 cascade p38-MAPK mitogen-activated kinase by avivagabriel on Aug 7, 2007, 3:58 PM- to inhibition tyrosine threonine proinflammatory chronic medicine p38-MAPK protein chemokines toxins inflammatory stress environmental pollutants activation cytokines pollution antiinflammatory interleukins phosphorylation kinases mitogen-activated inflammation by avivagabriel on Aug 7, 2007, 1:19 PM
Dr. Noboru Ashida, Department of Geriatric Medicine, Graduate School of Medicine, Kyoto University, 54 Kawaramachi, Shogoin Sakyo-ku, Kyoto 606-8507, Japan...Dr. Noboru Ashida, Department of Geriatric Medicine, Graduate School of Medicine, Kyoto University, 54 Kawaramachi, Shogoin Sakyo-ku, Kyoto 606-8507, Japan. Voice +81-75-751-3465; fax: +81-75-751-3574; ash@kuhp.kyoto.u.ac.jp.
to medicine coronary integrin kinase cardiovascular protein inflammation plaque p38-MAPK p38 cardiology occlusion inflammatory mitogen-activated artery cytokines atherosclerosis chemotaxis by avivagabriel on Jul 27, 2007, 10:56 PM- to development kinase inhibitors glaxosmithkline glaxo MAPK p38 drug mitogen-activated GSK atherosclerosis by avivagabriel on Jul 27, 2007, 1:29 PM
- to cytokines cardiology kinase coagulation fibrinogen anticoagulant endothelial fibrinolysis p38 endothelium inflammation protein inhibitors mitogen-activated inflammatory immunology cardiovascular by avivagabriel on Jul 27, 2007, 1:39 AM
HEMOSTASIS, THROMBOSIS, AND VASCULAR BIOLOGY. Judith Branger, Bernt van den Blink, Sebastiaan Weijer, Abhya Gupta, Sander J.H. van Deventer, C. Erik Hack, ...HEMOSTASIS, THROMBOSIS, AND VASCULAR BIOLOGY. Judith Branger, Bernt van den Blink, Sebastiaan Weijer, Abhya Gupta, Sander J.H. van Deventer, C. Erik Hack, Maikel P. Peppelenbosch, and Tom van der Poll
to p38 inhibitors cardiology coagulation neointima inflammatory cell endothelium fibrinolysis protein vascular cardiovascular immunology inflammation fibrinogen cytokines lamina kinase endothelial mitogen-activated cellular by avivagabriel on Jul 27, 2007, 1:30 AMThe anti-inflammatory potential of an oral p38 MAPK inhibitor in humans in vivo suggests that p38 MAPK inhibitors may provide a new therapeutic option in t...The anti-inflammatory potential of an oral p38 MAPK inhibitor in humans in vivo suggests that p38 MAPK inhibitors may provide a new therapeutic option in the treatment of inflammatory diseases. Boehringer Ingelheim. 2002 Branger J, et al
to ingelheim mitogen-activated p38 cardiovascular cytokines inhibitors immunology inflammation boehringer development drug inflammatory cardiology kinase protein by avivagabriel on Jul 27, 2007, 12:43 AMp38 MAPK inhibitors represent a novel therapeutic approach to the treatment of restenosis associated with coronary angioplasty.
to vascular injury neointima 2001 MAPK glaxosmithkline cardiology cardiovascular inflammation cytokines drug pharmacology novel GSK fibronectin inflammatory mitogen-activated development willette protein kinase remodeling inhibitors by avivagabriel on Jul 27, 2007, 12:27 AM
::
avivagabriel ::
